Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors. - Wikidata - wikimedia - TriplyDB

Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors.

Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors.

http://www.wikidata.org/entity/Q35751039

about

Adjuvant for vaccine immunotherapy of cancer--focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity The Yin and Yang of Toll-like receptors in cancer Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues Targeting tumor-associated macrophages to combat pancreatic cancer Anticancer efficacy of a supramolecular complex of a 2-diethylaminoethyl-dextran-MMA graft copolymer and paclitaxel used as an artificial enzyme Along the Axis between Type 1 and Type 2 Immunity; Principles Conserved in Evolution from Fish to Mammals Microenvironmental regulation of tumor progression and metastasis Vaccine-induced myeloid cell population dampens protective immunity to SIV Ultrastructural localization of intravenously injected carbon nanohorns in tumor.Toll-like receptors and cancer, particularly oral squamous cell carcinoma.Therapeutic effect of human iPS-cell-derived myeloid cells expressing IFN-β against peritoneally disseminated cancer in xenograft models.Immune cells: more than simple carriers for systemic delivery of oncolytic viruses.Balancing the innate immune system in tumor development.Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment.Trial Watch: Experimental Toll-like receptor agonists for cancer therapy TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis Jacalin-Activated Macrophages Exhibit an Antitumor Phenotype Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer.TLR3 agonists and proinflammatory antitumor activities.Application potential of toll-like receptors in cancer immunotherapy: Systematic review.Targeting tumor-infiltrating macrophages to combat cancer.Platelet-derived growth factor-C (PDGF-C) induces anti-apoptotic effects on macrophages through Akt and Bad phosphorylation Intratumoral immunization: a new paradigm for cancer therapy.Oxidative stress in apoptosis and cancer: an update.Anti-tumour strategies aiming to target tumour-associated macrophages.Targeting TLR3 with no RIG-I/MDA5 activation is effective in immunotherapy for cancer.Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines.Tumor-associated macrophages as major players in the tumor microenvironment.Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking Association between Toll-like receptor 3 polymorphisms and cancer risk: a meta-analysis.Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands.Modulating the innate immune activity in murine tumor microenvironment by a combination of inducer molecules attached to microparticles.Medicinal facilities to B16F10 melanoma cells for distant metastasis control with a supramolecular complex by DEAE-dextran-MMA copolymer/paclitaxel.Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.Regulation of cancer stem cell activities by tumor-associated macrophages Exploiting poly(I:C) to induce cancer cell apoptosis.Toll-like receptor 3 regulates NK cell responses to cytokines and controls experimental metastasis.Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site.Biphasic function of TLR3 adjuvant on tumor and spleen dendritic cells promotes tumor T cell infiltration and regression in a vaccine therapy.TAMable tumor-associated macrophages in response to innate RNA sensing.

P2860

Q26782131-06DA0084-11B8-4C1E-A64C-D2A43B730254 Q26851526-CA83E9A9-CB99-4B97-85A8-5DC0AAF078A3 Q27003907-86E79CFF-84F5-4604-A5FB-E7C5E870C6B0 Q28076103-8EF641CF-EBF3-490F-9D68-ABAB5686A598 Q28083180-C1553DE1-9405-4A38-A335-CF267667CCF8 Q28083360-CF80ED0F-6EFF-4EFB-B5E4-62279AF17515 Q29615504-576DCB88-7BCF-4B24-B5B1-5365436A3BEA Q33685961-819F6D0B-58C2-48E0-BAE1-BC7565324C12 Q33968761-3AE1E2A0-E19A-4799-8D14-8F6A33B56010 Q34239239-433D711D-59EF-4F26-94F0-F339CAF2EC01 Q34797365-55D5F105-6B88-4219-9AA3-E55C76119D39 Q35162284-58146085-5A56-4F9C-AAAD-23BC7B40795D Q35236394-610C001B-E791-406F-B6BB-6DE9F58C82C6 Q36107932-0D7613A4-0CDF-4FE4-9CB0-B6A0981EBE24 Q36194849-FFF32CF3-1ACD-4489-BA52-3E298B63179E Q36373374-0D5C9B6A-EB26-44A4-8E3C-EB27E70F6757 Q36789467-399A9492-D507-44A9-BA39-C7A60F6B9C41 Q37017190-1CC5B55D-62F2-44C3-94A9-CE99737096EA Q37136200-27706230-8465-411B-8957-2665CB2756F1 Q37205171-ACFD4C21-3731-4A4A-9157-B95311773B54 Q37401717-0C57D777-945B-40C6-896B-AAFF9069D4E0 Q37608572-78E3B80B-2EC8-40C6-AD02-4CB11627354F Q37691837-1FCA17D8-22D6-4240-AC24-3EB6FDDD03F4 Q38027434-66217FEC-EBE9-4CC9-A453-D35FEAD424C4 Q38056746-0967205F-1009-4D32-94C0-FE910A4654B2 Q38081981-B251C833-AE01-43A4-9223-440160A0CE9A Q38154151-3BF2E3E8-3046-4584-A342-5B375A23111C Q38240110-6516C21F-3E01-45E0-A54D-E015A815688A Q38288055-20A79E0E-3CA8-42D9-9EC4-9AFD0330695D Q38398013-47F34B56-4836-4581-86E0-E7B49BF43161 Q38781955-17C595AF-8B92-4B81-9DB6-CF37F2DE217D Q38868855-1CB78CE6-3B2D-401B-8C85-60133651C845 Q38897843-460CA877-4688-4346-9948-A2267F7C2FA8 Q39280710-E9806289-AF0D-439B-9E6D-4F6D04E87968 Q39556754-A2B85CF5-8962-47DB-ABB4-FEEF2CDB5173 Q40062585-6226DF03-C7CE-4285-84AF-1C863F3EFD96 Q40502877-47C1C165-C35A-4449-9E24-909295E2BB88 Q40576387-7E8861EF-3978-4EB3-AE1F-847289469A1C Q40994269-166B2598-BD3C-40FF-B67E-ED48F7D456C5 Q41475520-7939419B-3D35-44E4-AFDC-F42695631517

P2860

Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors.

http://www.wikidata.org/entity/Q35751039

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Toll-like receptor 3 signaling ...... ells to tumoricidal effectors.

@ast

Toll-like receptor 3 signaling ...... ells to tumoricidal effectors.

@en

type

label

Toll-like receptor 3 signaling ...... ells to tumoricidal effectors.

@ast

Toll-like receptor 3 signaling ...... ells to tumoricidal effectors.

@en

prefLabel

Toll-like receptor 3 signaling ...... ells to tumoricidal effectors.

@ast

Toll-like receptor 3 signaling ...... ells to tumoricidal effectors.

@en

P1433

Q35751039-9660D1B1-1906-434A-90D2-163307EAED48

P1476

Q35751039-3CB15FCD-67EA-42A5-9C81-F3379652EB42

P2093

Q35751039-24F85DD2-208C-437C-8078-4ECE9CC67D73

Q35751039-2DF779C9-2CA9-4452-A0F3-6678209B4FEC

Q35751039-426314CF-B165-4BEB-95DD-829B6AFF6093

Q35751039-4DF1A533-FD8F-4A9B-884E-E0D26F8BA05C

Q35751039-6BBB63A6-09F4-458A-9BFB-4704CB8867E2

Q35751039-808DE719-5DA9-45A8-BF9F-15A77AE44B64

Q35751039-8C283646-34E5-4713-BDFD-0DCFFA94AA2F

Q35751039-AF955476-6CE5-4CF1-9D61-6F8F37514F56

P2860

Q35751039-019D802E-38B1-4B8C-B481-1088FA56DCFC

Q35751039-06C0361B-B9B7-4086-AFED-B8281541F0FC

Q35751039-0A448336-D788-45BC-A873-03270684DBB1

Q35751039-0F764110-C91D-4FBD-85ED-EC5F5A172455

Q35751039-1547FE1E-134B-4EA7-97F2-9B0D53077190

Q35751039-1903F903-B00F-4741-BC3E-DA16A9456309

Q35751039-1B439711-E991-46F6-B022-7D88D894A12D

Q35751039-224EBAA0-C7D5-43D5-B575-CBE9C9796ACA

Q35751039-22E3A12C-B030-401C-B8A9-E6B13BAA5B2C

Q35751039-2EF14934-4CCA-40DF-AC29-F29174E401E6

P304

Q35751039-FCC1687D-7254-40DF-9735-57663EE79F84

P31

Q35751039-0DBD4286-6357-483C-8F83-42AE14EABC71

P356

Q35751039-EECCEB40-30FC-49B8-B559-1F6CB1B7E421

P407

Q35751039-D6F7E521-3EB1-4279-A119-2BF46DD91BB2

P433

Q35751039-E2CA77CA-2AFD-4EC9-B1FA-730620232891

P478

Q35751039-78A51710-433C-4C30-BF51-EA1A1E05C0CC

P50

Q35751039-7E7C09BA-E832-4F96-B43E-6AD8E758C517

P577

Q35751039-12C3AAE9-1BE8-453D-A816-62F898354838

P5875

Q35751039-288FACC8-8F95-42AE-B6E8-977EA7F2A5A7

P698

Q35751039-D36B95BE-7B27-4A18-8AF7-E553129D47A1

P921

Q35751039-5CA1CD0E-2858-4F12-91AF-EB7B65C74B55

P932

Q35751039-53D33606-FC43-491A-B91E-DA08A01FDD8A

P356

PNAS.1113099109

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Toll-like receptor 3 signaling ...... ells to tumoricidal effectors.

@en

P2093

Akio Nakane

http://www.w3.org/2001/XMLSchema#string

Hideaki Tahara

http://www.w3.org/2001/XMLSchema#string

Hiroaki Shime

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Oshiumi

http://www.w3.org/2001/XMLSchema#string

Misako Matsumoto

http://www.w3.org/2001/XMLSchema#string

Norimitsu Inoue

http://www.w3.org/2001/XMLSchema#string

Shinya Tanaka

http://www.w3.org/2001/XMLSchema#string

Tsukasa Seya

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer: The oncogene-driven connection

Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation

An endotoxin-induced serum factor that causes necrosis of tumors

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

Immunity, Inflammation, and Cancer

Pattern recognition receptors and inflammation

The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses

Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation

Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88

P304

2066-2071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1113099109

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Yoichiro Iwakura

P577

2012-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221808859

http://www.w3.org/2001/XMLSchema#string

P698

22308357

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

3277567

http://www.w3.org/2001/XMLSchema#string